CompletedPHASE1, PHASE2NCT00789776

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fred Hutchinson Cancer Center
Principal Investigator
Brenda Sandmaier
Fred Hutch/University of Washington Cancer Consortium
Intervention
Allogeneic Bone Marrow Transplantation(procedure)
Enrollment
41 enrolled
Eligibility
All sexes
Timeline
20082017

Study locations (3)

Collaborators

National Cancer Institute (NCI) · The Wayne D. Kuni and Joan E. Kuni Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00789776 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials